Showing results (51-60 of 59) with videos related to
Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
Cancer Research|May 19, 2005
Association of DNA methylation of phosphoserine aminotransferase with response to endocrine therapy in patients with recurrent breast cancerJohn W M Martens, Inko Nimmrich, Thomas Koenig, et al.Breast Cancer Research and Treatment|October 30, 2007
DNA hypermethylation of PITX2 is a marker of poor prognosis in untreated lymph node-negative hormone receptor-positive breast cancer patientsInko Nimmrich, Anieta M Sieuwerts, Marion E Meijer-van Gelder, et al.The Journal of Clinical Investigation|March 17, 2015
Tumor cell migration screen identifies SRPK1 as breast cancer metastasis determinantWies van Roosmalen, Sylvia E Le Dévédec, Ofra Golani, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 2004
The prognostic value of BCAR1 in patients with primary breast cancerLambert C J Dorssers, Nicolai Grebenchtchikov, Arend Brinkman, et al.Molecular & Cellular Proteomics : MCP|April 19, 2014
Ferritin heavy chain in triple negative breast cancer: a favorable prognostic marker that relates to a cluster of differentiation 8 positive (CD8+) effector T-cell responseNing Qing Liu, Tommaso De Marchi, Annemieke M Timmermans, et al.Journal of the National Cancer Institute|January 9, 2014
Comparative proteome analysis revealing an 11-protein signature for aggressive triple-negative breast cancerNing Qing Liu, Christoph Stingl, Maxime P Look, et al.Oncogene|January 23, 2018
IGF1R signaling drives antiestrogen resistance through PAK2/PIX activation in luminal breast cancerYinghui Zhang, Lynn Wester, Jichao He, et al.Journal of the National Cancer Institute|January 17, 2002
Pooled analysis of prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in 8377 breast cancer patientsMaxime P Look, Wim L J van Putten, Michael J Duffy, et al.Plos Genetics|July 28, 2010
Ancestry-shift refinement mapping of the C6orf97-ESR1 breast cancer susceptibility locusSimon N Stacey, Patrick Sulem, Carlo Zanon, et al.Pageof 6